TCRT
Alaunos Therapeutics, Inc.
+0.03 (+2.34%)1.31USD11.2K成交股數3.3M市值–本益比(近四季)1109.3股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0-100% | 0-100% | 0 | 0-100% | 2K+100% | 5K | 0-100% | 4K | 1K | 0 | 4K | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 388K | 427K | 469K | 185K | 347K | −87K | 143K | 180K | 126K | 3.7M | 5.2M | 6.5M |
| 銷售管理費用 | 564K | 585K | 718K | 854K | 747K | 846K | 1.0M | 990K | 1.6M | 3.6M | 3.0M | 3.2M |
| 營業利益 | −952K-13% | −1.0M+34% | −1.2M+3% | −1.0M-11% | −1.1M-37% | −754K-91% | −1.2M-86% | −1.2M-88% | −1.7M | −8.7M | −8.0M | −9.7M |
| 營業利益率 | – | – | – | – | -54,600.0% | -15,080.0% | – | -29,150.0% | -174,200.0% | – | -199,550.0% | – |
| 稅後淨利 | −952K-11% | −1.0M+36% | −1.2M+3% | −1.1M-7% | −1.1M-36% | −741K-91% | −1.1M-87% | −1.1M-89% | −1.7M | −8.5M | −8.8M | −10.0M |
| 淨利率 | – | – | – | – | -53,650.0% | -14,820.0% | – | -28,225.0% | -168,200.0% | – | -219,325.0% | – |
| 稀釋 EPS | -0.41-39% | -0.59+28% | -0.55-21% | -0.63-11% | -0.67-36% | -0.46-91% | -0.70-87% | -0.71+13% | -1.05 | -5.30 | -5.49 | -0.63 |
| 稀釋股數 | 2.4M | 1.9M | 2.2M | 1.7M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 16.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 124K | 354K | 1.9M | 2.9M | 319K | 1.1M | 1.7M | 2.5M | 4.1M | 11.9M | 18.3M | 23.5M |
| 應收帳款 | 0 | 0 | 0 | 2K | 2K | 5K | 0 | 4K | 1K | 0 | 4K | 0 |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.5M | 1.9M | 3.7M | 4.7M | 2.1M | 2.8M | 3.6M | 4.7M | 6.0M | 19.4M | 27.9M | 48.6M |
| 有息負債 | – | – | – | – | – | 0 | – | – | 0 | – | – | – |
| 總負債 | 864K | 595K | 921K | 1.1M | 1.1M | 692K | 826K | 907K | 1.2M | 5.5M | 6.3M | 19.1M |
| 股東權益 | 652K | 1.3M | 2.8M | 3.7M | 1.1M | 2.1M | 2.7M | 3.8M | 4.8M | 13.9M | 21.7M | 29.5M |
| 負債比 | 57.0% | 31.6% | 24.7% | 22.7% | 50.1% | 25.1% | 23.3% | 19.4% | 20.5% | 28.5% | 22.5% | 39.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | 1.1M | – | – | 4.1M | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.0M | – | – | −772K-60% | – | – | – | −1.9M | – | – | −9.4M |
| 資本支出 | – | – | – | – | – | – | – | – | 0 | – | – | 61K |
| 自由現金流 | – | – | – | – | – | – | – | – | −1.9M | – | – | −9.4M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -191,700.0% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 5K | -50.0% | −4.2M | -83,520.0% | -2.20 | −3.0M |
| FY2024 | 10K | +100.0% | −4.7M | -46,790.0% | -2.92 | −5.0M |
| FY2023 | 5K | -99.8% | −4.7M | -93,580.0% | -21.97 | −30.3M |
| FY2022 | 2.9M | +634.2% | −37.7M | -1,291.2% | -2.61 | −29.4M |
| FY2021 | 398K | – | −78.8M | -19,786.7% | -0.37 | −64.8M |
| FY2020 | 0 | – | −80.0M | –% | -0.38 | −66.8M |
| FY2019 | – | – | −118M | –% | -0.70 | −41.1M |
| FY2018 | 146K | – | −53.1M | -36,381.5% | 0.96 | −49.9M |